abstract |
According to the present invention, the presence or absence of a risk of acquiring Alzheimer's disease or an onset risk thereof can be determined by measuring glycoalbumin and hemoglobin A1c in a blood sample and calculating a glycoalbumin/hemoglobin A1c ratio. By using the glycoalbumin/hemoglobin A1c ratio, moreover, a compound for treating or preventing Alzheimer's disease can be screened. |